Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasutaka Yamamoto

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Biomedical Research (Tokyo, Japan)|February 23, 2013
Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemiaYusuke Harada, Yasutaka Yamamoto, Shunsuke Tsujimoto, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2016
Streptococcal Infection-related Nephritis (SIRN) Manifesting Membranoproliferative Glomerulonephritis Type IKen Iseri, Masayuki Iyoda, Yasutaka Yamamoto, et al.
CEN Case Reports|February 16, 2022
Bilateral renal subcapsular hematoma caused by polyarteritis nodosa: a case reportYui Kambayashi, Ken Iseri, Yasutaka Yamamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2011
Cytosolic phospholipase A2alpha contributes to blood pressure increases and endothelial dysfunction under chronic NO inhibitionKohei Tanaka, Yasutaka Yamamoto, Kazuhide Ogino, et al.
International Journal of Molecular Medicine|July 20, 2016
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γShunsuke Tsujimoto, Manabu Kishina, Masahiko Koda, et al.
European Journal of Pharmacology|November 3, 2009
The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb modelKohei Tanaka, Yasutaka Yamamoto, Shunsuke Tsujimoto, et al.
Journal of Cardiovascular Pharmacology|August 25, 2009
Fenofibrate enhances neovascularization in a murine ischemic hindlimb modelAkira Katayama, Yasutaka Yamamoto, Kohei Tanaka, et al.
Plos One|June 30, 2016
Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous NephropathyKei Hihara, Masayuki Iyoda, Shohei Tachibana, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 28, 2002
The status of hypertension management in Japan in 2000Yasutaka Yamamoto, Kazuhiko Sonoyama, Koichi Matsubara, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 12, 2009
Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemiaYasutaka Yamamoto, Takashi Matsuura, Genta Narazaki, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Biomedical Research (Tokyo, Japan)|February 23, 2013
Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemiaYusuke Harada, Yasutaka Yamamoto, Shunsuke Tsujimoto, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2016
Streptococcal Infection-related Nephritis (SIRN) Manifesting Membranoproliferative Glomerulonephritis Type IKen Iseri, Masayuki Iyoda, Yasutaka Yamamoto, et al.
CEN Case Reports|February 16, 2022
Bilateral renal subcapsular hematoma caused by polyarteritis nodosa: a case reportYui Kambayashi, Ken Iseri, Yasutaka Yamamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2011
Cytosolic phospholipase A2alpha contributes to blood pressure increases and endothelial dysfunction under chronic NO inhibitionKohei Tanaka, Yasutaka Yamamoto, Kazuhide Ogino, et al.
International Journal of Molecular Medicine|July 20, 2016
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γShunsuke Tsujimoto, Manabu Kishina, Masahiko Koda, et al.
European Journal of Pharmacology|November 3, 2009
The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb modelKohei Tanaka, Yasutaka Yamamoto, Shunsuke Tsujimoto, et al.
Journal of Cardiovascular Pharmacology|August 25, 2009
Fenofibrate enhances neovascularization in a murine ischemic hindlimb modelAkira Katayama, Yasutaka Yamamoto, Kohei Tanaka, et al.
Plos One|June 30, 2016
Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous NephropathyKei Hihara, Masayuki Iyoda, Shohei Tachibana, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 28, 2002
The status of hypertension management in Japan in 2000Yasutaka Yamamoto, Kazuhiko Sonoyama, Koichi Matsubara, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 12, 2009
Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemiaYasutaka Yamamoto, Takashi Matsuura, Genta Narazaki, et al.
Pageof 6